CLEVELAND, Jan. 7, 2013 /PRNewswire/ -- Midwest healthcare companies attracted $996 million in new investments across 182 companies in 2012 according to the BioEnterprise Midwest Healthcare Venture Investment Report. The total dollars attracted is up by twenty-three percent from 2011. Ohio ($292 million), Minnesota ($165 million), and Illinois ($146 million) led Midwestern states in attracting investment dollars; Cleveland, Minneapolis, and Chicago were the leaders among Midwest regions.
"Investment activity in Midwest healthcare deals continues its upward trend, outperforming previous years' activity for 3 years in a row.
As with the rest of the country, Midwest healthcare investing fell dramatically in 2009 after strong years in 2007 and 2008, but it appears investors are again optimistic about Midwest deals. 2013 should be an interesting year to watch," said Aram Nerpouni, Interim President of BioEnterprise, the Cleveland biomedical accelerator.
By sector, the 2012 equity funding was allocated as follows:
"The Midwest typically sees more medical device companies than either healthcare IT or biopharmaceutical; however, biotech saw the largest influx of dollars in 2012 as investors continue to focus on later stage biotech opportunities," said Nerpouni. "Investment activity in Midwest healthcare IT remains robust as investors are drawn by payers and providers searching for applications to improve patient outcomes and efficiencies."
The Midwest Healthcare Venture Investment Report includes all reported numbers and regionally collected data. For co
|SOURCE BioEnterprise Corporation|
Copyright©2012 PR Newswire.
All rights reserved